J Diabetes Metab Dis
The Journal of Diabetes and Metabolic Disorders (J Diabetes Metab Dis, ISSN 2251-6581) is a peer-reviewed, open-access scientific journal dedicated to advancing knowledge in the fields of diabetes, endocrinology, and metabolic diseases. Published by Springer Nature, the journal serves as a comprehensive platform for disseminating high-quality research that addresses the pathophysiology, epidemiology, prevention, diagnosis, and management of diabetes and related metabolic disorders, including obesity, dyslipidemia, and metabolic syndrome. The scope encompasses a broad range of topics, from molecular mechanisms and genetic studies to clinical trials, translational research, and public health interventions. The journal welcomes original research articles, comprehensive reviews, short communications, case reports, and letters to the editor, ensuring a diverse representation of scholarly work. Its target audience includes clinicians, endocrinologists, diabetologists, nutritionists, pharmacologists, and basic science researchers seeking current evidence and innovative perspectives in metabolic health. As of 2026, the journal holds a Journal Citation Reports (JCR) Impact Factor of 2.100 and is ranked in the Q3 quartile within its subject area (classified as 4区医学 in the Chinese Academy of Sciences scheme), indicating a solid, mid-tier standing in the competitive field of metabolic and endocrine research. The open-access model ensures that all published content is freely available to the global scientific community, enhancing the visibility and impact of the research it publishes. With a focus on both fundamental science and clinical application, the journal remains a valuable resource for those aiming to understand and combat the growing burden of diabetes and metabolic diseases worldwide.